Transcriptional control of macrophage polarisation in type 2 diabetes

Semin Immunopathol. 2019 Jul;41(4):515-529. doi: 10.1007/s00281-019-00748-1. Epub 2019 May 2.

Abstract

Type-2 diabetes (T2D) is considered today as an inflammatory disease. Inflammatory processes in T2D are orchestrated by macrophage activation in different organs. Macrophages undergo classical M1 pro-inflammatory or alternative M2 anti-inflammatory activation in response to tissue microenvironmental signals. These subsets of macrophages are characterised by their expression of cell surface markers, secreted cytokines and chemokines. Transcriptional regulation is central to the polarisation of macrophages, and several major pathways have been described as essential to promote the expression of specific genes, which dictate the functional polarisation of macrophages. In this review, we summarise the current knowledge of transcriptional control of macrophage polarisation and the role this plays in development of insulin resistance.

Keywords: And transcription; Diabetes; Inflammation; Macrophage.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cellular Microenvironment / immunology*
  • Diabetes Mellitus, Type 2 / immunology*
  • Diabetes Mellitus, Type 2 / pathology
  • Humans
  • Insulin Resistance / immunology*
  • Macrophages / immunology*
  • Macrophages / pathology
  • Signal Transduction / immunology*
  • Transcription, Genetic / immunology*